Dimensional Fund Advisors
CYCN icon

Dimensional Fund Advisors’s Cyclerion Therapeutics CYCN Stock Holding History

Dimensional Fund Advisors’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,253
Closed -$50K – 3473
2022
Q1 		$50K Sell
2,253
-3,840
-63% -$92.5K ﹤0.01% 3464
2021
Q4 		$210K Sell
6,093
-805
-12% -$38K ﹤0.01% 3329
2021
Q3 		$424K Sell
6,898
-1,052
-13% -$68.8K ﹤0.01% 3215
2021
Q2 		$620K Buy
7,950
+4,893
+160% +$306K ﹤0.01% 3117
2021
Q1 		$171K Sell
3,057
-130
-4% -$9.76K ﹤0.01% 3308
2020
Q4 		$195K Buy
3,187
+255
+9% +$17.4K ﹤0.01% 3225
2020
Q3 		$357K Sell
2,932
-92
-3% -$10.5K ﹤0.01% 3124
2020
Q2 		$357K Sell
3,024
-2,617
-46% -$219K ﹤0.01% 3133
2020
Q1 		$299K Buy
5,641
+4,232
+300% +$302K ﹤0.01% 3147
2019
Q4 		$77K Buy
+1,409
New +$132K ﹤0.01% 3330
2019
Q3 		– Sell
-886
Closed -$203K – 3425
2019
Q2 		$203K Buy
+886
New +$251K ﹤0.01% 3320

Other funds holding CYCN

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TFS
TrustCore Financial Services Brentwood, Tennessee $1.14B AUM 13.32% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

Dimensional Fund Advisors's CYCN Position: Q2 2022 in Review

Dimensional Fund Advisors sold out of Cyclerion Therapeutics (CYCN) in Q2 2022, closing a stake of 2,253 shares — an estimated $50K sold.

Dimensional Fund Advisors first reported a position in CYCN in Q2 2019 and held it in 11 quarters. The position peaked at $620K in Q2 2021. 41 funds tracked by Wall St. Rank hold CYCN as of Q2 2022.

  • Dimensional Fund Advisors reported no remaining Cyclerion Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 2,253 Cyclerion Therapeutics shares in Q2 2022, an estimated $50K.
  • Dimensional Fund Advisors first reported a position in Cyclerion Therapeutics in Q2 2019 and held it in 11 quarters.
  • Dimensional Fund Advisors's Cyclerion Therapeutics position peaked at $620K in Q2 2021.
  • 41 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q2 2022.

Based on Dimensional Fund Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.